Ken Griffin’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
Ken Griffin's ROIV Position: Q3 2026 in Review
Ken Griffin reduced its Roivant Sciences (ROIV) stake by 83% in Q3 2026, selling an estimated $167M and leaving 962,603 shares worth $35.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1915.
Ken Griffin first reported a position in ROIV in Q2 2022 and has held it in 18 quarters since. The position peaked at $197M in Q2 2026. 522 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- Ken Griffin held 962,603 shares of Roivant Sciences worth $35.2M as of Q3 2026.
- Ken Griffin sold 4,613,658 Roivant Sciences shares in Q3 2026, an estimated $167M.
- Roivant Sciences made up ﹤0.01% of Ken Griffin's portfolio in Q3 2026, its #1915 holding.
- Ken Griffin first reported a position in Roivant Sciences in Q2 2022 and has held it in 18 quarters since.
- Ken Griffin's Roivant Sciences position peaked at $197M in Q2 2026.
- 522 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.